Claims in HRT Drugs Case Timely, Ariz. Federal Judge Rules

PHOENIX — An Arizona federal judge has allowed the pro se plaintiff in a hormone therapy replacement case to proceed with her claim of negligence and replead her failure-to-warn and fraud claims, finding she could not have known or discovered with reasonable diligence that the drugs were a potential cause of her breast cancer until October 2010.

In a May 3 order, Judge David G. Campbell of the U.S. District Court for the District of Arizona rejected the defendant drug makers’ assertion that the plaintiff should have known of the potential cause of her injury when the Women’s Health Initiative …